azacitidine has been researched along with B-Cell Lymphoma in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Huang, D; Lin, H; Liu, L; Wang, A; Wang, Y | 1 |
| Bitsani, C; Dimitrakopoulou, A; Dimou, M; Kotsanti, S; Kyrtsonis, MC; Panayiotidis, P; Papaioannou, P; Petsa, P; Roumelioti, M | 1 |
| Bruederlein, S; Färbinger, J; Gehringer, F; Guan, H; Holzmann, K; Leithäuser, F; Möller, P; Ritz, O; Ushmorov, A; Vogel, MJ; Weitzer, CD; Wirth, T; Xie, L | 1 |
| Bai, Y; Jiang, X; Ren, G; Shi, H; Shi, Y; Wang, J; Wang, L; Zhang, X; Zhou, R | 1 |
| Aiba, K; Hayashi, K; Homma, S; Ito, M; Kamata, Y; Kan, S; Nagasaki, E | 1 |
| Asnafi, V; Bruneau, J; Cheminant, M; Couronne, L; Delarue, R; Derrieux, C; Frenzel, L; Guermouche, H; Hermine, O; Kosmider, O; Lemonnier, F; Lhermitte, L; Macintyre, E; Molina, T; Saillard, C; Suarez, F; Trinquand, A | 1 |
| Hiraga, J; Kinoshita, T; Kiyoi, H; Naoe, T; Shimada, K; Sugimoto, T; Tomita, A | 1 |
| Haleem, K; Sen, N; Siddique, AB; Simmons, WJ; Thomas, RM; Tsiagbe, VK; Zhang, DJ | 1 |
| Aozasa, K; Hoshida, Y; Nakatsuka, S; Nishii, K; Nishiu, M; Takakuwa, T; Tomita, Y; Yamaguchi, M; Yang, WI | 1 |
| Ambinder, RF; Chan, AT; Flinn, IW; Johnson, PJ; Klencke, B; Kwan, WH; Leung, TW; Mann, RB; Robertson, KD; Tao, Q | 1 |
| Harada, M; Ishimaru, F; Ito, S; Ogama, Y; Ouchida, M; Shimizu, K; Shiote, Y; Takimoto, H; Tanimoto, M; Yoshino, T | 1 |
| Altomonte, M; Calabrò, L; Colizzi, F; Fonsatti, E; Gattei, V; Maio, M; Nanni, P; Pezzani, L; Sigalotti, L | 1 |
| Agrelo, R; Artiga, MJ; Espada, J; Esteller, M; Fraga, MF; Pérez-Rosado, A; Piris, MA; Rodriguez, M; Sanchez-Aguilera, A; Setien, F | 1 |
| Kinoshita, T; Li, Y; Murohara, T; Nagai, H; Ohashi, H; Ohno, T; Saito, H | 1 |
| Akao, Y; Kinoshita, T; Kitade, Y; Nakagawa, Y; Naoe, T | 1 |
| Ambinder, RF; Barletta, J; Robertson, KD; Samid, D | 1 |
| Chiang, Y; Davis, RG; Vishwanatha, JK | 1 |
| Carbone, A; Mittnacht, S; Platt, G | 1 |
| Basham, TY; Merigan, TC; Reid, TR | 1 |
19 other study(ies) available for azacitidine and B-Cell Lymphoma
| Article | Year |
|---|---|
Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Humans; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Myelodysplastic Syndromes | 2022 |
High-grade B-cell lymphoma of the peritoneum as a result of transformation of a CD5-negative monoclonal B lymphocytosis population in a patient with myelodysplastic syndrome treated with 5-azacytidine.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; CD5 Antigens; Humans; Lymphocytosis; Lymphoma, B-Cell; Male; Myelodysplastic Syndromes; Peritoneum; Prognosis | 2018 |
FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.
Topics: Apoptosis; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Down-Regulation; Epigenomics; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Lymphoma, B-Cell; Mediastinal Neoplasms; Signal Transduction | 2014 |
[Significance of expression and promoter methylation of LITAF gene in B-cell lymphoma].
Topics: Adult; Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Gene Silencing; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Nuclear Proteins; Polymerase Chain Reaction; Promoter Regions, Genetic; Transcription Factors | 2014 |
Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation.
Topics: Antigens, CD20; Azacitidine; Cell Line, Tumor; Complement System Proteins; Cytotoxicity, Immunologic; Deoxycytidine; Gemcitabine; Humans; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; NF-kappa B; Rituximab; Thalidomide; Up-Regulation | 2016 |
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.
Topics: Aged, 80 and over; Azacitidine; Female; Humans; Leukemia, Myelomonocytic, Chronic; Lymphoma, B-Cell; Lymphoma, T-Cell | 2017 |
Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Azacitidine; Cell Line, Tumor; Cytidine Triphosphate; DNA Methylation; Down-Regulation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Histone Deacetylase 1; Humans; Lymphoma, B-Cell; Promoter Regions, Genetic; Repressor Proteins; Rituximab; Sin3 Histone Deacetylase and Corepressor Complex | 2009 |
Regulation of mouse mammary tumor virus env transcriptional activator initiated mammary tumor virus superantigen transcripts in lymphomas of SJL/J mice: role of Ikaros, demethylation, and chromatin structural change in the transcriptional activation of ma
Topics: Animals; Azacitidine; Chromatin; Deoxyribonuclease I; DNA Methylation; DNA-Binding Proteins; Female; Genes, env; Hydroxamic Acids; Ikaros Transcription Factor; Lymphoma, B-Cell; Mammary Tumor Virus, Mouse; Mice; Promoter Regions, Genetic; Retroviridae Infections; RNA, Messenger; Superantigens; Trans-Activators; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured; Tumor Virus Infections | 2003 |
Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies.
Topics: Antibodies, Monoclonal; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; B-Lymphocytes; Calcium-Calmodulin-Dependent Protein Kinases; CpG Islands; Death-Associated Protein Kinases; Decitabine; DNA Methylation; Enzyme Induction; fas Receptor; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Jurkat Cells; Killer Cells, Natural; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, B-Cell; Lymphoma, T-Cell; Neoplasm Proteins; Neoplastic Stem Cells; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes | 2003 |
Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.
Topics: Antigens, Viral, Tumor; Azacitidine; Base Sequence; DNA Methylation; DNA-Cytosine Methylases; DNA, Viral; Enzyme Inhibitors; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Nasopharyngeal Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic | 2004 |
Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
Topics: Azacitidine; Cadherins; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Gene Expression; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prognosis; Promoter Regions, Genetic; RNA, Messenger | 2004 |
Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implications.
Topics: Antigens, Neoplasm; Azacitidine; Blotting, Western; Cell Line, Tumor; Decitabine; DNA Methylation; Humans; Immunoprecipitation; Immunotherapy; Lymphoma, B-Cell; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Up-Regulation | 2005 |
Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Topics: Antimetabolites, Antineoplastic; Azacitidine; CpG Islands; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Lamin Type A; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Promoter Regions, Genetic; Survival Rate; Tumor Cells, Cultured | 2005 |
Aberrant DNA demethylation in promoter region and aberrant expression of mRNA of PAX4 gene in hematologic malignancies.
Topics: Azacitidine; Cell Line; Cell Proliferation; Decitabine; DNA Methylation; Gene Expression Profiling; Homeodomain Proteins; Humans; Lymphadenitis; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Paired Box Transcription Factors; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity | 2006 |
Downregulation of microRNAs-143 and -145 in B-cell malignancies.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Burkitt Lymphoma; Cell Line, Tumor; Cell Survival; Decitabine; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Lymphoma, B-Cell; MicroRNAs; RNA, Neoplasm; Tumor Cells, Cultured | 2007 |
Pharmacologic activation of expression of immunodominant viral antigens: a new strategy for the treatment of Epstein-Barr-virus-associated malignancies.
Topics: Adult; Antigens, Viral; Azacitidine; Base Sequence; Burkitt Lymphoma; Decitabine; DNA-Binding Proteins; DNA, Neoplasm; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunodominant Epitopes; Lymphoma, B-Cell; Methylation; Molecular Sequence Data; Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Virus Infections; Viral Matrix Proteins; Virus Activation | 1995 |
Altered expression of annexin II in human B-cell lymphoma cell lines.
Topics: Alkaline Phosphatase; Annexin A2; Azacitidine; B-Lymphocytes; Cell Nucleus; Decitabine; DNA Modification Methylases; Enzyme Inhibitors; Gene Expression; Humans; Immune Sera; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Phosphorylation; RNA, Messenger; Tumor Cells, Cultured | 1996 |
p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma.
Topics: Adenoviridae; Azacitidine; Blotting, Western; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Decitabine; DNA Methylation; DNA Primers; Down-Regulation; Gene Deletion; Herpesvirus 8, Human; Humans; Lymphoma, B-Cell; Mutation; Polymerase Chain Reaction; Retinoblastoma Protein; RNA, Neoplasm; Sarcoma, Kaposi; Signal Transduction; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2002 |
Resistance to interferon-alpha in a mouse B-cell lymphoma involves DNA methylation.
Topics: Animals; Azacitidine; DNA; Drug Resistance; Ethyl Methanesulfonate; Interferon-alpha; Lymphoma, B-Cell; Methylation; Mice; Mutagenesis; Tumor Cells, Cultured | 1992 |